A very informative day spent at the Longitude Prize on AMR #UTIevent2020. POC diagnostics are certainly needed across primary care in the #NHS- we'll be sure to keep you updated on our progress! #UTI #AMR #PointofCare #Diagnostics

A new simple blood test for brain tumours that could be used by GPs in primary care is being developed thanks to Cancer Research UK funding of nearly £500,000 bristol.ac.uk/news/2020/febr…

Bristol scientists are working to reduce the demands on antibiotics. From 'molecular tyre shredders’ to ‘making bacteria self-digest', we cover the latest tech being developed in the city. Read more in the second part of our antibiotic resistance series: unitdx.com/the-bristol-sc…

Bristol is a hub of activity for research into antibiotic resistance. We examined four innovators in the region, all hoping to reduce the demand for antibiotics. unitdx.com/the-bristol-sc…

#COVID19 virus causes some flu-like symptoms. It’s important to remember not to take antibiotics to treat #COVID19. They won’t work and increase the risk of antimicrobial resistance #AMR. Find out more in the thread ⬇️ (1/3)

Antibiotics are a common prescription for people with #COVID19. But this is raising the risk that more bacteria will become resistant, undermining hospital care globally | Maryn McKenna #StopSuperbugs wired.com/story/covid-19…

Thank you to Neciah from FluoretiQ dropping in to our online #Science #Entrepreneur #Experience to chat about entrepreneurship and his experience of starting up

For #INWED20, we're delighted to highlight CTO and co-founder of FluoretiQ, 𝗝𝗼𝘀𝗲𝗽𝗵𝗶𝗻𝗲 𝗗𝗼𝗿𝗵. Together with her team, Josephine is working to fight #antimicrobial #resistance with a rapid point of care #diagnostics platform. #ShapeTheWorld 🌍

'Global use of broad-spectrum antibiotics rising, data show' #StopSuperbugs cidrap.umn.edu/news-perspecti…

As a virus ravages the world, antibiotic makers are in disarray pbs.org/newshour/show/…

Neciah Dorh, FluoretiQ lets us in on their P5 solution for #UrinaryTractInfections #diagnostics at the #pitch session of the AMR Conference

FluoretiQ FluoretiQ is winner of the AMR Conference Start-up campus #pitch session! Huge congrats to Neciah Dorh, CEO & Co-Founder of FluoretiQ! 🎉

And the winner is... (drum rolls please) 🥁🥁🥁 ‼️ FluoretiQ ‼️ Hats off to this #StartUp revolutionising bacterial diagnostics for taking home the Winner Prize of the #AMRConference Start-up Campus! Stay up-to-date, + insights will be published soon: amr-conference.com

A huge thank you to @AMRconference and everybody involved at the event. Watch this space for more exciting news! #Diagnostics #AMR

Want to learn more about our #AMRConference #startup winner FluoretiQ? In a short interview CEO Neciah Dorh explains how the technology helps to reduce the time to diagnose bacterial infections #diagnostics #AMR #UTI amr-conference.com/uncategorized/…

Launch of our new Cancer Research UK project for early detection of brain tumours. Great talks from partners and funders - K. Kurian (Co-PI), M. Carmen Galan, FluoretiQ, @richard36418277, brainstrust, and Science and Innovation at Cancer Research UK. Cross-disciplinary team from Bristol Cancer. bristol.ac.uk/cancer/events/…

Great to be at Silicon Gorge this afternoon! Good luck to all the pitching companies, including our members @Data_Cubed_Ltd & @Kaedim_ as well as University of Bristol @qtecbristol #startups FluoretiQ, Forefront RF, Phase Biolabs & Siloton. techSPARK #Bristol #Bristoltech

We’re proud to have been shortlisted for the KPMG competition. Good luck to Neciah who’s pitching our business today and everyone else who’s been shortlisted!

Want to see the future of UTI diagnostics? Visit us at BAUS Stand 112 for an exclusive product preview! BAUS Kasra Saeb-Parsy #Diagnostics #AMR #BAUS23 #Urology

We're here at BAUS- see the future of UTI diagnostics! Visit our booth at Stand 112 for an exclusive product preview #FirstPrescriptionRightPrescription #BAUS2023